Review of microdialysis in brain tumors, from concept to application: First annual Carolyn Frye-Halloran symposium

Ramsis K. Benjamin, Fred H. Hochberg, Elizabeth Fox, Peter M. Bungay, William F. Elmquist, Clinton F. Stewart, James M. Gallo, Jerry M. Collins, Robert P. Pelletier, John F. de Groot, Robert C. Hickner, Idil Cavus, Stuart A Grossman, O. Michael Colvin

Research output: Contribution to journalArticle

Abstract

In individuals with brain tumors, pharmacodynamic and pharmacokinetic studies of therapeutic agents have historically used analyses of drug concentrations in serum or cerebrospinal fluid, which unfortunately do not necessarily reflect concentrations within the tumor and adjacent brain. This review article introduces to neurological and medical oncologists, as well as pharmacologists, the application of microdialysis in monitoring drug metabolism and delivery within the fluid of the interstitial space of brain tumor and its surroundings. Microdialysis samples soluble molecules from the extracellular fluid via a semipermeable membrane at the tip of a probe. In the past decade, it has been used predominantly in neurointensive care in the setting of brain trauma, vasospasm, epilepsy, and intracerebral hemorrhage. At the first Carolyn Frye-Halloran Symposium held at Massachusetts General Hospital in March 2002, the concept of microdialysis was extended to specifically address its possible use in treating brain tumor patients. In doing so we provide a rationale for the use of this technology by a National Cancer Institute consortium, New Approaches to Brain Tumor Therapy, to measure levels of drugs in brain tissue as part of phase 1 trials.

Original languageEnglish (US)
Pages (from-to)65-74
Number of pages10
JournalNeuro-Oncology
Volume6
Issue number1
DOIs
StatePublished - Jan 2004

Fingerprint

Microdialysis
Brain Neoplasms
Extracellular Fluid
National Cancer Institute (U.S.)
Drug Monitoring
Cerebral Hemorrhage
General Hospitals
Pharmaceutical Preparations
Cerebrospinal Fluid
Epilepsy
Pharmacokinetics
Technology
Membranes
Brain
Therapeutics
Serum

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Clinical Neurology

Cite this

Benjamin, R. K., Hochberg, F. H., Fox, E., Bungay, P. M., Elmquist, W. F., Stewart, C. F., ... Colvin, O. M. (2004). Review of microdialysis in brain tumors, from concept to application: First annual Carolyn Frye-Halloran symposium. Neuro-Oncology, 6(1), 65-74. https://doi.org/10.1215/S1152851703000103

Review of microdialysis in brain tumors, from concept to application : First annual Carolyn Frye-Halloran symposium. / Benjamin, Ramsis K.; Hochberg, Fred H.; Fox, Elizabeth; Bungay, Peter M.; Elmquist, William F.; Stewart, Clinton F.; Gallo, James M.; Collins, Jerry M.; Pelletier, Robert P.; de Groot, John F.; Hickner, Robert C.; Cavus, Idil; Grossman, Stuart A; Colvin, O. Michael.

In: Neuro-Oncology, Vol. 6, No. 1, 01.2004, p. 65-74.

Research output: Contribution to journalArticle

Benjamin, RK, Hochberg, FH, Fox, E, Bungay, PM, Elmquist, WF, Stewart, CF, Gallo, JM, Collins, JM, Pelletier, RP, de Groot, JF, Hickner, RC, Cavus, I, Grossman, SA & Colvin, OM 2004, 'Review of microdialysis in brain tumors, from concept to application: First annual Carolyn Frye-Halloran symposium', Neuro-Oncology, vol. 6, no. 1, pp. 65-74. https://doi.org/10.1215/S1152851703000103
Benjamin, Ramsis K. ; Hochberg, Fred H. ; Fox, Elizabeth ; Bungay, Peter M. ; Elmquist, William F. ; Stewart, Clinton F. ; Gallo, James M. ; Collins, Jerry M. ; Pelletier, Robert P. ; de Groot, John F. ; Hickner, Robert C. ; Cavus, Idil ; Grossman, Stuart A ; Colvin, O. Michael. / Review of microdialysis in brain tumors, from concept to application : First annual Carolyn Frye-Halloran symposium. In: Neuro-Oncology. 2004 ; Vol. 6, No. 1. pp. 65-74.
@article{dde358610aa44644a6a483778adc1b35,
title = "Review of microdialysis in brain tumors, from concept to application: First annual Carolyn Frye-Halloran symposium",
abstract = "In individuals with brain tumors, pharmacodynamic and pharmacokinetic studies of therapeutic agents have historically used analyses of drug concentrations in serum or cerebrospinal fluid, which unfortunately do not necessarily reflect concentrations within the tumor and adjacent brain. This review article introduces to neurological and medical oncologists, as well as pharmacologists, the application of microdialysis in monitoring drug metabolism and delivery within the fluid of the interstitial space of brain tumor and its surroundings. Microdialysis samples soluble molecules from the extracellular fluid via a semipermeable membrane at the tip of a probe. In the past decade, it has been used predominantly in neurointensive care in the setting of brain trauma, vasospasm, epilepsy, and intracerebral hemorrhage. At the first Carolyn Frye-Halloran Symposium held at Massachusetts General Hospital in March 2002, the concept of microdialysis was extended to specifically address its possible use in treating brain tumor patients. In doing so we provide a rationale for the use of this technology by a National Cancer Institute consortium, New Approaches to Brain Tumor Therapy, to measure levels of drugs in brain tissue as part of phase 1 trials.",
author = "Benjamin, {Ramsis K.} and Hochberg, {Fred H.} and Elizabeth Fox and Bungay, {Peter M.} and Elmquist, {William F.} and Stewart, {Clinton F.} and Gallo, {James M.} and Collins, {Jerry M.} and Pelletier, {Robert P.} and {de Groot}, {John F.} and Hickner, {Robert C.} and Idil Cavus and Grossman, {Stuart A} and Colvin, {O. Michael}",
year = "2004",
month = "1",
doi = "10.1215/S1152851703000103",
language = "English (US)",
volume = "6",
pages = "65--74",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Review of microdialysis in brain tumors, from concept to application

T2 - First annual Carolyn Frye-Halloran symposium

AU - Benjamin, Ramsis K.

AU - Hochberg, Fred H.

AU - Fox, Elizabeth

AU - Bungay, Peter M.

AU - Elmquist, William F.

AU - Stewart, Clinton F.

AU - Gallo, James M.

AU - Collins, Jerry M.

AU - Pelletier, Robert P.

AU - de Groot, John F.

AU - Hickner, Robert C.

AU - Cavus, Idil

AU - Grossman, Stuart A

AU - Colvin, O. Michael

PY - 2004/1

Y1 - 2004/1

N2 - In individuals with brain tumors, pharmacodynamic and pharmacokinetic studies of therapeutic agents have historically used analyses of drug concentrations in serum or cerebrospinal fluid, which unfortunately do not necessarily reflect concentrations within the tumor and adjacent brain. This review article introduces to neurological and medical oncologists, as well as pharmacologists, the application of microdialysis in monitoring drug metabolism and delivery within the fluid of the interstitial space of brain tumor and its surroundings. Microdialysis samples soluble molecules from the extracellular fluid via a semipermeable membrane at the tip of a probe. In the past decade, it has been used predominantly in neurointensive care in the setting of brain trauma, vasospasm, epilepsy, and intracerebral hemorrhage. At the first Carolyn Frye-Halloran Symposium held at Massachusetts General Hospital in March 2002, the concept of microdialysis was extended to specifically address its possible use in treating brain tumor patients. In doing so we provide a rationale for the use of this technology by a National Cancer Institute consortium, New Approaches to Brain Tumor Therapy, to measure levels of drugs in brain tissue as part of phase 1 trials.

AB - In individuals with brain tumors, pharmacodynamic and pharmacokinetic studies of therapeutic agents have historically used analyses of drug concentrations in serum or cerebrospinal fluid, which unfortunately do not necessarily reflect concentrations within the tumor and adjacent brain. This review article introduces to neurological and medical oncologists, as well as pharmacologists, the application of microdialysis in monitoring drug metabolism and delivery within the fluid of the interstitial space of brain tumor and its surroundings. Microdialysis samples soluble molecules from the extracellular fluid via a semipermeable membrane at the tip of a probe. In the past decade, it has been used predominantly in neurointensive care in the setting of brain trauma, vasospasm, epilepsy, and intracerebral hemorrhage. At the first Carolyn Frye-Halloran Symposium held at Massachusetts General Hospital in March 2002, the concept of microdialysis was extended to specifically address its possible use in treating brain tumor patients. In doing so we provide a rationale for the use of this technology by a National Cancer Institute consortium, New Approaches to Brain Tumor Therapy, to measure levels of drugs in brain tissue as part of phase 1 trials.

UR - http://www.scopus.com/inward/record.url?scp=9144233488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144233488&partnerID=8YFLogxK

U2 - 10.1215/S1152851703000103

DO - 10.1215/S1152851703000103

M3 - Article

C2 - 14769143

AN - SCOPUS:9144233488

VL - 6

SP - 65

EP - 74

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 1

ER -